Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Designed as a launchpad for innovation, the Global Headquarters and Centre for Research & Development includes seven stories …
CSL Behring is once again hosting the Mark Cuban Foundation’s Artificial Intelligence Bootcamp in Philadelphia. Interested hi…
Along with other breast cancer survivors, CSL Seqirus’ Jennifer Maroon finds community and inspiration in dragon boating.
The National Hemophilia Foundation changed its name and officially broadened its mission to include all bleeding disorders. G…
Before they head to campus, students who want a parent’s help managing a chronic health condition should take steps to get me…
Furthering its commitment to a healthier world, the global company appointed Jeffrey Ball, an in-house leader who has been he…
As he nears his one-year anniversary as site leader, Abner Garcia-Delgado talked with the Daily Journal about his management …
Dr. Shirley Abraham, who heads a Hemophilia Treatment Center in New Mexico, answers three important questions for parents.
Membership expands access to scientific partners and talent in the Boston corridor – one of the world’s premier hubs for rese…
Americas
Asia Pacific
Middle East
Europe